Fastenal (NASDAQ: FAST) EVP receives grant of 13,719 stock options

Rhea-AI Filing Summary

Fastenal Company executive Donnalee Kathleen Papenfuss, EVP-Strategy and Communication, reported a new grant of 13,719 employee stock options. These options give her the right to buy Fastenal common stock at an exercise price of $41 per share. The award was granted on 01/02/2026 and is held directly.

According to the filing, all 13,719 derivative securities were acquired as a single grant and 13,719 derivative securities were beneficially owned following the transaction. The options expire on 12/31/2035 and will vest over four years, with 25% of the grant vesting and becoming exercisable each year after the grant date.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Papenfuss Donnalee Kathleen

(Last) (First) (Middle)

2001 THEURER BOULEVARD

(Street)

WINONA MN 55987

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
FASTENAL CO [ FAST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP-Strategy and Communication

3. Date of Earliest Transaction (Month/Day/Year)
01/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$41	01/02/2026		A		13,719		(1)	12/31/2035	Common Stock	13,719	$0	13,719	D

Explanation of Responses:

1. The option will fully vest and become exercisable over a period of four years, with 25% vesting and becoming exercisable each year following the grant date.

Remarks:

	/s/ John J. Milek, Attorney-in-Fact	01/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Fastenal (FAST) report in this Form 4?

The Form 4 reports that Donnalee Kathleen Papenfuss, Executive Vice President-Strategy and Communication of Fastenal Company, received a grant of 13,719 employee stock options on 01/02/2026.

How many stock options were granted to Fastenal EVP Donnalee Papenfuss and at what exercise price?

Donnalee Papenfuss was granted 13,719 employee stock options (right to buy) with a $41 exercise price per share of Fastenal common stock.

What is the vesting schedule for the 13,719 Fastenal employee stock options?

The filing states that the option will fully vest and become exercisable over four years, with 25% vesting and becoming exercisable each year following the 01/02/2026 grant date.

When do the reported Fastenal stock options held by Donnalee Papenfuss expire?

The 13,719 employee stock options reported in the filing have an expiration date of 12/31/2035, after which they can no longer be exercised.

Does the Form 4 show whether the Fastenal options are held directly or indirectly?

The Form 4 indicates that the 13,719 employee stock options are held with direct (D) ownership, with no separate indirect ownership entity noted.

How many derivative securities did Donnalee Papenfuss beneficially own after this Fastenal option grant?

Following the reported grant on 01/02/2026, the Form 4 shows that Donnalee Papenfuss beneficially owned 13,719 derivative securities related to this employee stock option award.